AVALO THERAPEUTICS INC (AVTX) Stock Earnings Estimates
NASDAQ:AVTX • US05338F3064
15.97 USD
+0.97 (+6.47%)
At close: Feb 19, 2026
15.97 USD
0 (0%)
After Hours: 2/19/2026, 8:00:01 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.05M 234.26% | 1.924M -89.34% | 441K -77.08% | -100.00% | 6.441M | 93.169M 1,346.50% | 129.61M 39.11% | 294.56M 127.27% | 543.78M 84.61% | ||||
| EBITDA YoY % growth | -37.27M 53.68% | -23.286M 37.52% | -40.702M -74.79% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -37.44M 54.41% | -23.444M 37.38% | -40.871M -74.33% | -71.403M -74.70% | -78.521M -9.97% | -100.254M -27.68% | -108.688M -8.41% | -130.064M -19.67% | -67.376M 48.20% | -67.385M -0.01% | 57.241M 184.95% | 265.63M 364.06% | |
| Operating Margin | -207.42% | -1,218.50% | -9,267.80% | N/A | N/A | N/A | N/A | -2,019.32% | -72.32% | -51.99% | 19.43% | 48.85% | |
| EPS YoY % growth | -1,075.20 55.02% | -488.22 54.59% | -164.27 66.35% | -6.20 96.23% | -5.17 16.69% | -4.19 18.96% | -3.44 17.76% | -4.05 -17.63% | -1.59 60.76% | -2.69 -69.02% | 3.21 219.62% | 6.28 95.56% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.49 81.22% | -1.56 -25.12% | -1.37 28.39% | -1.29 41.13% | -1.22 18.03% |
| Revenue Q2Q % growth | -100.00% | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -19.392M -45.68% | -19.466M -29.77% | -19.13M -0.68% | -19.398M -1.04% | -19.737M -1.78% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -2.19 -75.20% | -1.69 | -0.50 | -29.44% |
| Q2 2025 Q2Q % growth | -1.92 86.35% | -1.43 | -0.49 | -33.98% |
| Q1 2025 Q2Q % growth | -1.25 99.11% | -1.41 | 0.16 | 11.62% |
| Q4 2024 Q2Q % growth | -7.95 93.16% | -0.40 | -7.55 | -1,889.97% |
| Q3 2024 Q2Q % growth | -1.25 95.27% | -1.21 | -0.04 | -2.98% |
| Q2 2024 Q2Q % growth | -14.07 90.06% | -6.83 | -7.24 | -105.88% |
| Q1 2024 Q2Q % growth | -141.00 30.88% | -1.20 | -139.80 | -11,614.86% |
| Q4 2023 Q2Q % growth | -116.22 53.44% | -4.90 | -111.32 | -2,273.67% |
| Q3 2023 Q2Q % growth | -26.40 -132.35% | -269.28 | 242.88 | 90.20% |
| Q2 2023 Q2Q % growth | -141.60 57.25% | -195.84 | 54.24 | 27.70% |
| Q1 2023 Q2Q % growth | -204.00 64.58% | -237.46 | 33.46 | 14.09% |
| Q4 2022 Q2Q % growth | -249.60 45.83% | -179.52 | -70.08 | -39.04% |
| Q3 2022 Q2Q % growth | 81.60 116.67% | -268.06 | 349.66 | 130.44% |
| Q2 2022 Q2Q % growth | -331.20 36.11% | -433.30 | 102.10 | 23.56% |
| Q1 2022 Q2Q % growth | -576.00 37.50% | -391.68 | -184.32 | -47.06% |
| Q4 2021 Q2Q % growth | -460.80 11.11% | -464.14 | 3.34 | 0.72% |
| Q3 2021 Q2Q % growth | -489.60 | -528.77 | 39.17 | 7.41% |
| Q2 2021 Q2Q % growth | -518.40 5.26% | -499.39 | -19.01 | -3.81% |
| Q1 2021 Q2Q % growth | -921.60 5.88% | -567.93 | -353.67 | -62.27% |
| Q4 2020 Q2Q % growth | -518.40 | -440.64 | -77.76 | -17.65% |
| Q3 2020 Q2Q % growth | -489.60 | -279.07 | -210.53 | -75.44% |
| Q2 2020 Q2Q % growth | -547.20 | -308.45 | -238.75 | -77.40% |
| Q1 2020 Q2Q % growth | -979.20 | -299.64 | -679.56 | -226.80% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -100.00% | % | ||
| Q4 2024 Q2Q % growth | 192K -66.37% | 192K | % | |
| Q3 2024 Q2Q % growth | 249K 5.51% | 249K | % | |
| Q2 2024 Q2Q % growth | -100.00% | % | ||
| Q1 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | 571K -36.56% | 306K | 265K | 86.60% |
| Q3 2023 Q2Q % growth | 236K -98.42% | 1.02M | -784K | -76.86% |
| Q2 2023 Q2Q % growth | 643K -37.57% | 510K | 133K | 26.08% |
| Q1 2023 Q2Q % growth | 475K -59.40% | 1.02M | -545K | -53.43% |
| Q4 2022 Q2Q % growth | 900K 309.09% | 3.683M | -2.783M | -75.56% |
| Q3 2022 Q2Q % growth | 14.95M 1,007.41% | 1.099M | 13.851M | 1,260.33% |
| Q2 2022 Q2Q % growth | 1.03M -69.35% | 806.82K | 223.18K | 27.66% |
| Q1 2022 Q2Q % growth | 1.17M 148.94% | 380.797K | 789.203K | 207.25% |
| Q4 2021 Q2Q % growth | 220K -85.33% | 1.038M | -818K | -78.81% |
| Q3 2021 Q2Q % growth | 1.35M 21.62% | 1.138M | 212K | 18.63% |
| Q2 2021 Q2Q % growth | 3.36M 150.75% | 3.629M | -269K | -7.41% |
| Q1 2021 Q2Q % growth | 470K -82.91% | 3.855M | -3.385M | -87.81% |
| Q4 2020 Q2Q % growth | 1.5M | 1.02M | 480K | 47.06% |
| Q3 2020 Q2Q % growth | 1.11M | 1.53M | -420K | -27.45% |
| Q2 2020 Q2Q % growth | 1.34M | 2.295M | -955K | -41.61% |
| Q1 2020 Q2Q % growth | 2.75M | 1.981M | 769K | 38.82% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -6.67% | 9% | -2.66% | -3.32% |
| Revenue | N/A | N/A | N/A | N/A |